Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
FL.19ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
FL.19ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
FM.2EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
FM.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FM.2ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
FM.2ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
FM.2EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
FM.2EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
FM.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
FM.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
FK.1.2EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
FK.1.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FK.1.2ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
FK.1.2ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
FK.1.2EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
FK.1.2EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
FK.1.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
FK.1.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.2.7.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
XBB.2.7.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.2.7.1ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
XBB.2.7.1ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
XBB.2.7.1EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
XBB.2.7.1EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
XBB.2.7.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBB.2.7.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
CR.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
KB.3EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
KB.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
KB.3ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
KB.3ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
KB.3EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
KB.3EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
KB.3ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
KB.3ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
GK.11EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
GK.11EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
GK.11ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
GK.11ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
GK.11EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
GK.11EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
GK.11ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
GK.11ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
CJ.1.3.2EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
CJ.1.3.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
CJ.1.3.2ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
CJ.1.3.2ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
CJ.1.3.2EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
CJ.1.3.2EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
CJ.1.3.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used